Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Additional chromosome abnormalities in chronic myeloid leukemia.

Hsiao HH, Liu YC, Tsai HJ, Hsu JF, Yang WC, Chang CS, Lin SF.

Kaohsiung J Med Sci. 2011 Feb;27(2):49-54. doi: 10.1016/j.kjms.2010.09.001.

2.

Cytogenetic & molecular analyses in adult chronic myelogenous leukaemia patients in north India.

Anand MS, Varma N, Varma S, Rana KS, Malhotra P.

Indian J Med Res. 2012;135:42-8.

3.

Serial monitoring of BCR-ABL transcripts in chronic myelogenous leukemia (CML) treated with imatinib mesylate.

Hardling M, Wei Y, Palmqvist L, Swolin B, Stockelberg D, Gustavsson B, Ekeland-Sjöberg K, Wadenvik H, Ricksten A.

Med Oncol. 2004;21(4):349-58.

PMID:
15579919
4.

First and second line imatinib treatment in chronic myelogenous leukemia patients expressing rare e1a2 or e19a2 BCR-ABL transcripts.

Andrikovics H, Nahajevszky S, Szilvási A, Bors A, Adám E, Kozma A, Kajtár B, Barta A, Poros A, Tordai A.

Hematol Oncol. 2007 Sep;25(3):143-7.

PMID:
17530620
5.

[Clinical efficacy and side effects of STI571 in treatment of patients with chronic myeloid leukemia].

Liu XL, Zhou SY, Du QF, Zheng WY, Zhang S, Song LL, Xu B, Liu QF, Meng FY.

Ai Zheng. 2004 Apr;23(4):421-5. Chinese.

PMID:
15087031
7.
8.

Cytogenetic correlation with disease status and treatment outcome in advanced stage leukemia post bone marrow transplantation: a Southwest Oncology Group study (SWOG-8612).

Slovak ML, Kopecky KJ, Wolman SR, Henslee-Downey JP, Appelbaum FR, Forman SJ, Blume KG.

Leuk Res. 1995 Jun;19(6):381-8.

PMID:
7596150
9.

[Cytogenetic and molecular analysis of 1193 cases with chronic myeloid leukemia].

Jiang DZ, Chen ZM, Lou JY, Wang YG, Liang Y, Jin J.

Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):1-5. Chinese.

PMID:
17649716
11.

High-dose imatinib mesylate therapy in newly diagnosed Philadelphia chromosome-positive chronic phase chronic myeloid leukemia.

Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Verstovsek S, Giles F, Rios MB, Shan J, Letvak L, Thomas D, Faderl S, Ferrajoli A, Cortes J.

Blood. 2004 Apr 15;103(8):2873-8. Epub 2003 Dec 24.

12.

Imatinib: a review of its use in chronic myeloid leukaemia.

Moen MD, McKeage K, Plosker GL, Siddiqui MA.

Drugs. 2007;67(2):299-320. Review.

PMID:
17284091
13.

Molecular responses in patients with chronic myelogenous leukemia in chronic phase treated with imatinib mesylate.

Cortes J, Talpaz M, O'Brien S, Jones D, Luthra R, Shan J, Giles F, Faderl S, Verstovsek S, Garcia-Manero G, Rios MB, Kantarjian H.

Clin Cancer Res. 2005 May 1;11(9):3425-32.

14.

Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase.

Jabbour E, Kantarjian HM, Abruzzo LV, O'Brien S, Garcia-Manero G, Verstovsek S, Shan J, Rios MB, Cortes J.

Blood. 2007 Oct 15;110(8):2991-5. Epub 2007 Jul 11.

15.

[Bone marrow morphologic features in patients treated with imatinib for Philadelphia chromosome positive chronic myeloid leukemia].

Jiang Q, Chen SS, Jiang B, Jiang H, Shi HL, Lu Y, Lu DP.

Zhonghua Xue Ye Xue Za Zhi. 2004 Mar;25(3):158-62. Chinese.

PMID:
15182585
16.

Clinical, morphological, cytogenetic and molecular aspects of a series of Ph-negative chronic myeloid leukemias.

Aurich J, Duchayne E, Huguet-Rigal F, Bauduer F, Navarro M, Perel Y, Pris J, Caballin MR, Dastugue N.

Hematol Cell Ther. 1998 Aug;40(4):149-58.

PMID:
9766919
17.
18.

Response to Imatinib mesylate in chronic myeloid leukemia patients with variant BCR-ABL fusion transcripts.

Sharma P, Kumar L, Mohanty S, Kochupillai V.

Ann Hematol. 2010 Mar;89(3):241-7. doi: 10.1007/s00277-009-0822-7. Epub 2009 Aug 29.

PMID:
19714331
19.
20.

Karyotype abnormalities and their clinical significance in a group of chronic myeloid leukemia patients treated with hematopoietic stem cell transplantation.

Otero L, Ornellas MH, de Azevedo AM, Tavares Rde C, Pires V, Abdelhay E, Bouzas LF, Fernandez Tde S.

Sao Paulo Med J. 2007 Jul 5;125(4):246-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk